Occupancy of dopamine D2 receptors by aripiprazole at steady state dosing in schizophrenia measured with [18F]fallypride PET

被引:0
|
作者
Frankle, WG [1 ]
Narendran, R [1 ]
Gil, R [1 ]
Hwang, DR [1 ]
Hwang, YY [1 ]
Scher, E [1 ]
Cangiano, C [1 ]
Laruelle, M [1 ]
Abi-Dargham, A [1 ]
机构
[1] Columbia Univ, NYSPI, New York, NY USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
716
引用
收藏
页码:219S / 219S
页数:1
相关论文
共 50 条
  • [1] Occupancy of dopamine D2 receptors by aripiprazole at steady state dosing in schizophrenia measured with [18F] fallypride PET
    Frankle, WG
    Narendran, R
    Gil, R
    Hwang, DR
    Hwang, YY
    Scher, E
    Cangiano, C
    Laruelle, M
    Abi-Dargham, A
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S116 - S116
  • [2] Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride
    Lawrence S Kegeles
    Mark Slifstein
    W Gordon Frankle
    Xiaoyan Xu
    Elizabeth Hackett
    Sung-A Bae
    Robyn Gonzales
    Jong-Hoon Kim
    Beatriz Alvarez
    Roberto Gil
    Marc Laruelle
    Anissa Abi-Dargham
    Neuropsychopharmacology, 2008, 33 : 3111 - 3125
  • [3] Dose-Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F] Fallypride
    Kegeles, Lawrence S.
    Slifstein, Mark
    Frankle, W. Gordon
    Xu, Xiaoyan
    Hackett, Elizabeth
    Bae, Sung-A
    Gonzales, Robyn
    Kim, Jong-Hoon
    Alvarez, Beatriz
    Gil, Roberto
    Laruelle, Marc
    Abi-Dargham, Anissa
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (13) : 3111 - 3125
  • [4] Sex differences in baseline dopamine D2 receptor occupancy in the amygdala using PET and [18F]fallypride
    Riccardi, P.
    Park, S.
    Carroll, X.
    Anderson, S.
    Davant, B.
    Bauernfeind, A.
    Schmidt, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 180 - 180
  • [5] DIFFERENTIAL OCCUPANCY OF STRIATAL VERSUS EXTRASTRIATAL DOPAMINE D2/D3 RECEPTORS BY THE TYPICAL ANTIPSYCHOTIC HALOPERIDOL IN MAN MEASURED USING I [18F]-FALLYPRIDE PET
    Dunn, J. T.
    Baker, S. X.
    Stone, J.
    Cleij, M.
    Marsden, P. K.
    O'Doherty, M.
    Reed, L. J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 : A33 - A33
  • [6] D2/D3 receptor binding in striatal and extrastriatal regions in schizophrenia measured with [18F]fallypride PET
    Kegeles, Lawrence S.
    Slifstein, M.
    Xu, X.
    Hackett, E.
    Gil, R.
    Alvarez, B.
    Meyers, E.
    Urban, N.
    Laruelle, M.
    Abi-Dargham, A.
    NEUROIMAGE, 2008, 41 : T52 - T52
  • [7] Striatal and Extrastriatal Dopamine Release Measured With PET and [18F] Fallypride
    Slifstein, Mark
    Kegeles, Lawrence S.
    Xu, Xiaoyan
    Thompson, Judy L.
    Urban, Nina
    Castrillon, John
    Hackett, Elizabeth
    Bae, S. -A.
    Laruelle, Marc
    Abi-Dargham, Anissa
    SYNAPSE, 2010, 64 (05) : 350 - 362
  • [8] Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains in vivo using consecutive PET scans of [18F]FPCIT and [18F]fallypride
    Choi, Jae Yong
    Kim, Chul Hoon
    Jeon, Tae Joo
    Cho, Won Gil
    Lee, Jin Suk
    Lee, Soo Jin
    Choi, Tae Hyun
    Kim, Byoung Soo
    Yi, Chi Hoon
    Seo, Youngbeom
    Yi, Dae Ik
    Han, Sang Jin
    Lee, Minkyung
    Kim, Dong Goo
    Lee, Jong Doo
    An, Gwangil
    Ryu, Young Hoon
    APPLIED RADIATION AND ISOTOPES, 2012, 70 (12) : 2689 - 2694
  • [9] Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography
    Kegeles, Lawrence S.
    Slifstein, Mark
    Xu, Xiaoyan
    Urban, Nina
    Thompson, Judy L.
    Moadel, Tiffany
    Harkavy-Friedman, Jill M.
    Gil, Roberto
    Laruelle, Marc
    Abi-Dargham, Anissa
    BIOLOGICAL PSYCHIATRY, 2010, 68 (07) : 634 - 641
  • [10] In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates
    Mark Slifstein
    Dah-Ren Hwang
    Yiyun Huang
    NingNing Guo
    Yasuhiko Sudo
    Raj Narendran
    Peter Talbot
    Marc Laruelle
    Psychopharmacology, 2004, 175 : 274 - 286